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Photochromic dithienylmaleimides are well known molecular switches, but for applications the suitable
functionalization of the photochromic scaﬀold is required. We report here synthetic routes to
dithienylmaleimides, which are functionalized at three diﬀerent positions: at each of the thiophene
moieties and the maleimide nitrogen. A Perkin-type condensation of two thiophene precursors is used
as the key step to assemble the maleimide core, which allows the synthesis of non-symmetrically
substituted dithienylmaleimides, such as photochromic amino acids. A diﬀerent approach to the
maleimide core is provided by the reaction of a dithienylmaleic anhydride with amines or hydrazides
leading to maleimide protected dithienylmaleimides and photochromic labeled natural amino acids. The
photochromic properties of the new photoswitches were investigated showing reversible
photochromism in polar organic solvents.Introduction
Photochromism has attracted great attention in materials
science1 and as a tool in molecular biology.2 A variety of appli-
cations are found inmolecular optoelectronics3 and optical data
storage.4–6 In the eld of life sciences, molecular switches have
been used to control enzyme activity,7–10 Watson–Crick base
pairing,11–13 the regulation of neuronal activity by photochromic
ligands for ion channels and receptors,14–20 antibiotic eﬀects21,22
and even the agility of a living organism23 by light. This broad
applicability is one of the reasons why photopharmacology has
evolved into a vibrant eld of research.24 Various photochromic
molecules, like azobenzenes,25 spiropyrans,26 spirooxazines,26
fulgides27 and diarylethenes28,29 have been developed. All these
photoswitches can be reversible toggled between two isomers
using light. The well investigated dithienylethenes (DTEs),
including dithienylmaleimides, are characterized by a nearly
quantitative photochemical conversion between the photo-
isomers, which are oen thermally stable. Irradiation with light
of a specic wavelength switches the DTEs between their open
and closed photoisomers, which diﬀer in conformational ex-
ibility and electronic conjugation (Fig. 1).
Many DTEs show high fatigue resistance.28 Despite their
outstanding photophysical properties the synthesis of DTEs, in
particular of non-symmetric derivatives, is laborious.13,30
Diﬀerent synthetic routes for the preparation of dithienylma-
leimides were established. Starting from 3,4-y of Regensburg, D-93051 Regensburg,
ESI) available: Additional experimental
all prepared compounds. See DOI:
hemistry 2015dibromomaleimides and 3,4-diiodomaleimides, respectively,
both thiophene moieties can be attached by palladium cata-
lyzed Suzuki coupling.31–33 However, only nitrogen protected
maleimides can be used and the synthesis of non-symmetric
compounds is challenging. Another route uses the reaction of
a dithienylmaleic anhydride with amines to the corresponding
maleimide.34–36 The synthesis of diarylmaleimides by intra-
molecular Perkin condensation of two independently prepared
precursors gives selective access to non-symmetric diary-
lmaleimides.10,37,38 Compared to diarylperuorocyclopentenes
and diarylcyclopentenes, diarylmaleimides are more hydro-
philic and better water soluble, which is valuable for applica-
tions in biology and pharmacy. The absorption maxima of
diarylmaleimides are shied to higher wavelengths and thus
the photoisomerization can be induced by light with lower
energy reducing potential cell damage.28 Moreover, the
biocompatibility of diarylmaleimides is known from bisindo-
lylmaleimides, for instance arcyriarubins and arcyriaavins
with antibiotic activities, several other potent protein kinaseFig. 1 Reversible photochemical isomerization of a dithienylmalei-
mide between the open and closed photoisomer by irradiation with
light of diﬀerent wavelength.
RSC Adv., 2015, 5, 18075–18086 | 18075
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View Article Onlineand sirtuin inhibitors.10,39–43 However, a better synthetic access
to functionalized photochromic dithienylmaleimides is desir-
able in order to extend their applications. Herein we discuss the
synthesis of functionalized dithienylmaleimides substituted on
each thiophene moiety and the maleimide nitrogen atom.
Results and discussion
Synthesis
Functionalization of the maleimide nitrogen atom. The
transformation of diarylmaleic anhydrides into their corre-
sponding diarylmaleimides provides an easy access to
compounds with a functionalized maleimide nitrogen atom.28
Complex functionalities or protecting groups can be introduced
at the maleimide nitrogen by reaction with amines or hydra-
zides. We used the adapted synthetic approach of Scandola
et al.36 for the synthesis of anhydride 4 as precursor (Scheme 1).
Methyl ester 2 was converted to its potassium salt 3 and
condensed in a Perkin reaction with carboxylic acid 1 yieldingScheme 1 Synthesis of dithienylmaleic anhydride 4.
Scheme 2 Synthesis of the functionalized photochromic dithienylmalei
18076 | RSC Adv., 2015, 5, 18075–18086the photochromic maleic anhydride 4. The anhydride moiety
allows the subsequent functionalization with hydrazides or
amines (Scheme 2). Therefore maleic anhydride 4 was treated
with a-Cbz protected L-glutamic acid g-hydrazide44 (5) and a-
Cbz protected L-lysine to give amino acids 6 and 7 with a
photochromic dithienylmaleimide on each sidechain. Photo-
chromic tripeptides forming hydrogels with diﬀerent aggrega-
tion modes mainly depending on the switch moiety were
recently reported.45 The reaction of hydrazine hydrate in acetic
acid as solvent and 1,2-dimethylhydrazine dihydrochloride,
respectively, with maleic anhydride 4 aﬀorded the maleimide
nitrogen protected dithienylmaleimides 8 and 9 in good yields
(Scheme 2). Remarkably, the formation of any maleic hydrazide
or other tautomers was not observed. The protected maleimides
8 and 9 could be used for further functionalizations on the
thiophene moieties by palladium-catalyzed cross coupling
reactions or other reactions using the reactivity of the heteroaryl
chlorides.
Functionalization as photochromic amino acid. Recently,
DTE-based non-natural amino acids were synthesized and
successfully introduced into small peptides.46 However, their
water-solubility is limited due to the diaryl per-
uorocyclopentene core and therefore we developed a more
polar dithienylmaleimide amino acid. Compounds 13a and 13b
were prepared by a Perkin condensation10,37,38 of the thiophene
precursors 10 and 11 bearing a protected primary amino or
carboxyl group, respectively (Scheme 3). The Alloc group was
chosen as a suitable protection for the amine as it is stable
during the synthesis of compound 12. Diester thiophene 11
provides in 4-position the carboxylic ester giving the maleimide
core in the Perkin condensation. The ester in 2-position will
serve as carboxylate of the amino acid. Both carboxylic acids
were protected as methyl ester. Alloc group and methyl ester of
12 were cleaved simultaneously with boron tribromide giving
amino acid 13a in 47% yield, accompanied by 20% of the Allocmides 6–9 starting from maleic anhydride 4.
This journal is © The Royal Society of Chemistry 2015
Scheme 3 Perkin condensation of thiophenes 10 and 11 yielding
dithienylmaleimide 12 and after deprotection 13a and 13b.
Scheme 4 Synthesis of thiophene 10.
Scheme 5 Synthesis of thiophene 11.
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View Article Onlineamino acid 13b as byproduct. A selective non-hydrolytic
deprotection of the methyl ester of 12 is possible in low yield
using lithium iodide in a polar aprotic solvent.47,48 A large excess
of lithium iodide and reux were necessary to achieve conver-
sion; several solvents were tested with best yields in acetone (see
ESI, Table S1†). Standard basic hydrolytic conditions for the
deprotection of the methyl ester aﬀorded the deprotected
maleic anhydride (see ESI, Scheme S2†). The synthesis of thio-
phene 10 is depicted in Scheme 4. Bromination49 of 2-methyl-
thiophene (14) and subsequent Rosenmund–von Braun
reaction50 giving nitrile 16 were performed according to litera-
ture procedures.
The reduction of nitrile 16 with lithium aluminum hydride
followed by immediate protection with allyl chloroformate
aﬀorded carbamate 17 in good yield. Using Fmoc chloride
instead led to the respective Fmoc derivative in lower yields
and caused the formation of side products in the subsequent
Friedel–Cras acylation. The yield of glyoxylester 18 in the
Friedel–Cras acylation depends critically on the sequence of
the reagent addition. Best results were obtained by mixing 17
and methyl chlorooxoacetate before adding aluminum chlo-
ride in small portions. Quenching the reaction with saturated
sodium hydrogen carbonate solution avoids the addition of
hydrochloric acid to the allyl double bond. Aminolysis with
aqueous ammonia converted the glyoxylester 18 in high yieldThis journal is © The Royal Society of Chemistry 2015into compound 10. The overall yield for 10 aer six steps is
22%.
Thiophene 11 was prepared by esterication51 of methyl-
thiophene acid 19 in the presence of thionyl chloride followed
by Friedel–Cras acylation and nally a thallium trinitrate
(TTN) mediated oxidative rearrangement52 (Scheme 5). All
intermediates were isolated in good to excellent yields with an
overall yield of 68% for three steps. Initial moderate yields for
the Friedel–Cras acylation of around 40% signicantly
increased to 77% aer rigorous removal of stabilizers from the
solvent chloroform.
Functionalization by Suzuki coupling. Dithienylmaleimides
are conveniently synthesized by the Perkin-type condensation.
The reaction of two precursors yields the maleimide core
without the need for protection of the maleimide nitrogen.
Scheme 6 shows the intramolecular Perkin condensation of theRSC Adv., 2015, 5, 18075–18086 | 18077
Scheme 6 Perkin condensation of 22 and 23 yielding dithienylma-
leimide 24.
Scheme 8 Synthesis of non-symmetric substituted dithienylethenes
35–37 by Perkin condensation.
RSC Advances Paper
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View Article Onlinetwo chlorosubstituted precursors 22 and 23. Both precursors
can be diﬀerently functionalized by Suzuki coupling before
used in the Perkin condensation yielding non-symmetric
dithienylmaleimides.
Recently, we described the synthesis of symmetric diary-
lmaleimides, with thiophene moieties functionalized by
palladium-catalysis prior to the condensation reaction.10 Based
on this strategy we prepared a small series of non-symmetric
diarylmaleimides (Scheme 7).
The Perkin condensation to the maleimide core was per-
formed under basic conditions combining the diﬀerentScheme 7 Synthesis of functionalized precursors 25–27 and 32–34.
18078 | RSC Adv., 2015, 5, 18075–18086thiophenes. Scheme 8 summarizes the synthesis of the non-
symmetric photoswitches 35–37.
Photochromic properties. The dithienylmaleimide core
structure can be toggled reversibly between a ring-open and
ring-closed photoisomer (Fig. 1). The photochemical properties
of photochromic compounds 4, 6–9, 12, 13a, 13b, 24 and 35–37
were investigated by UV-Vis spectroscopy. Despite of reports
that diarylmaleimides are not able to undergo photo-
isomerization in polar solvents due to a twisted intramolecular
charge transfer (TICT),53–55 we could observe reversible photo-
isomerization of the dithienylmaleimides 6–9, 12, 13a, 13b, 24
and 35–37 in methanol or dimethylsulfoxide, respectively. Fig. 2
shows the changes of the UV-Vis spectra of compound 12 upon
irradiation with light of 312 nm (Herolab, 6 W).
Upon irradiating a methanol solution of the ring-open form
of compound 12 with UV light (312 nm), the absorption band atFig. 2 Changes of the UV-Vis absorption spectra of dithienylmalei-
mide amino acid 12 (50 mM in MeOH) upon light irradiation with
312 nm; arrows indicate the changes of the absorption maxima over
42 s irradiation in periods of 6 s (Herolab, 6 W); the cuvettes show the
color of the solution before and after irradiation.
This journal is © The Royal Society of Chemistry 2015
Fig. 3 Cycle performance of the dithienylmaleimide amino acid 12
(50 mM in MeOH). Changes in absorption at 554 nm were measured
during alternate irradiation with light of 312 nm for 60 s (Herolab, 6 W)
and 530 nm (CREE-XP green, 700 mA) for 5 min.
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View Article Online250 nm immediately decreases. Simultaneously, new absorp-
tion maxima at 232 nm, 378 nm and 550 nm arise (Fig. 2)
causing the color change of the sample from slightly yellow to
purple. The isosbestic points indicate a clean conversion
between two components. Compared to typical DTE-
cyclopentenes the absorption maxima are red shied. The
photostationary state was reached aer 42 s of irradiation
(Herolab, 312 nm, 6 W) and the open form can be regained by
irradiation with visible light (>420 nm) for 5 min. The photo-
switchable amino acid 12 is stable over at least seven closing/
opening cycles (Fig. 3).
The absorption maxima and their corresponding extinction
coeﬃcients for the open and closed form of all synthesized
photochromic compounds are summarized in Table 1. Inter-
estingly, the long wavelength absorption maximum of
compound 13a is blue shied to 537 nm compared to photo-
switches 12 and 13b, which may indicate an interaction of the
Alloc group with the dithienylmaleimide core. In contrast the
selective removal of the methyl ester has almost no inuence on
the photochromic properties. In comparison to bischloroTable 1 UV-Vis spectroscopic data of the open and closed (PSS) form o
Compound Solvent Conc. [mM]
4 MeOH 100
6 DMSO 50
7 DMSO 50
8 DMSO 50
9 DMSO 50
12 MeOH 50
13a MeOH 50
13b MeOH 50
24 MeOH 50
35 MeOH 100
36 MeOH 100
37 MeOH 100
a UV-Vis spectroscopic data are reported for solutions at 25 C and reported
of solutions of the open isomer with light of 312 nm (Herolab, 6 W). b Sh
This journal is © The Royal Society of Chemistry 2015dithienylmaleimide 24 the functionalized maleimides 35–37
show a bathochromic shi in their absorption maxima of the
closed photoisomer. The enlarged p-system of the substituted
thiophenes can explain this shi to higher wavelengths.Conclusions
In summary, we have prepared several photochromic dithie-
nylmaleimides. Maleimide nitrogen atom functionalized
derivatives were obtained by the reaction of dithienylmaleic
anhydride with diﬀerent hydrazides and amines. Using a
Perkin-type condensation non-symmetric dithienylmaleimides
were synthesized including a photochromic amino acid and
dithienylmaleimides with diﬀerent aromatic substituents on
each thiophene moiety. Reversible photoisomerization in
dimethylsulfoxide and methanol was observed for all synthe-
sized photochromic compounds.Experimental section
General information
Commercial reagents and starting materials were purchased
from Acros Organics, Alpha-Aesar, Fluka, Sigma Aldrich or VWR
and used without further purication. Solvents were used in p.a.
quality and dried according to common procedures, if neces-
sary. To purify the chloroform for Friedel–Cras acylations, it
was washed with sulfuric acid (1 M), dried over calcium chlo-
ride, ltered through silica, subsequently reuxed with phos-
phorus pentoxide (5–10 g L1) and distilled under nitrogen
atmosphere. Compounds 1,10 2,10 5,44 15,49 16,50 20,51 22,10 25,10
28,10 29 10 and 32 10 were prepared according to previously
reported procedures. Flash column chromatography was per-
formed on a Biotage Isolera One automated ash purication
system with UV/Vis detector using Sigma Aldrich MN silica gel
60 M (40–63 mm, 230–400mesh) for normal phase or pre-packed
Biotage SNAP cartridges (KP-C18-HS) for reversed phase chro-
matography. Reaction monitoring via TLC was performed on
alumina plates coated with silica gel (Merck silica gel 60 F254,
0.2 mm). Melting points were determined using a Stanfordf the synthesized photochromic compoundsa
lmax open (3) lmax closed (3)
242 (26.0), 298 (9.5) 359 (16.0), 523 (3.7)
387 (4.6) 359 (17.4), 510 (3.2)
381 (5.0) 355 (20.8), 500 (4.1)
386 (6.0) 359 (22.7), 508 (4.3)
380 (3.3) 351 (12.9), 498 (2.7)
250 (18.5) 232 (16.2), 378 (13.6), 550 (3.9)
252 (13.0) 231 (11.3), 375 (10.0), 537 (2.7)
250 (14.3) 232 (12.6), 378 (10.3), 549 (2.8)
240 (20.2), 370 (4.5) 234 (20.6), 352 (13.8), 497 (2.5)
264 (18.5), 292 (17.1) 369 (9.7), 543 (3.0)
255 (28.8), 291b (14.3) 369 (10.1), 540 (3.7)
262 (26.1), 297 (20.7) 391 (11.5), 586 (5.7)
in nm (lmax) and 10
3 cm1 M1 (3). The PSS were obtained by irradiation
oulder.
RSC Adv., 2015, 5, 18075–18086 | 18079
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View Article OnlineResearch Systems OptiMelt MPA 100. NMR spectra were recor-
ded on a Bruker Avance 300 (1H 300.13 MHz, 13C 75.48 MHz),
Bruker Avance 400 (1H 400.13 MHz, 13C 100.61 MHz) or Avance
III 600 (1H 600.25 MHz, 13C 150.95 MHz) instrument. The
spectra are referenced against the NMR-solvent, chemical shis
are reported in ppm and coupling constants J are given in Hz.
Resonance multiplicity is abbreviated as: s (singlet), d (doublet),
t (triplet), m (multiplet) and b (broad). Carbon NMR signals are
reported with (+) for primary/tertiary, () for secondary and (q)
for quaternary carbons. The assignment resulted from DEPT,
HSQC andHMBC experiments. Mass spectra were recorded on a
Finnigan MAT95 (EI-MS), Agilent Q-TOF 6540 UHD (ESI-MS,
APCI-MS), Finnigan MAT SSQ 710 A (EI-MS, CI-MS) or Ther-
moQuest Finnigan TSQ 7000 (ES-MS, APCI-MS) spectrometer.
UV/Vis absorption spectroscopy was performed using a Varian
Cary BIO 50 UV/Vis/NIR spectrometer. IR-spectra were recorded
with a Specac Golden Gate Diamond Single Reection ATR
System in a Bio-Rad FT-IR-Spectrometer Excalibur FTS 3000 and
peak positions are reported in wavenumbers (cm1). Standard
hand-held lamps were used for visualizing TLC plates and to
carry out the ring-closure reactions at 312 nm (Herolab, 312 nm,
6 W). The ring-opening reactions were performed with the light
of a 200 W tungsten light bulb which was passed through a 420
nm cut-oﬀ lter to eliminate higher energy light or the light of a
green LED (CREE-XP green, 530 nm, 700 mA). The power of the
light is given based on the specications supplied by the
company when the lamps were purchased. A light detector was
not used to measure the intensity during the irradiation
experiments.
3,4-Bis(5-chloro-2-methylthiophen-3-yl)furan-2,5-dione (4)
To obtain the potassium salt 3, the ester 2 was dissolved in EtOH
(2.5 mL mmol1) and KOH (1.0 eq.) was added. Aer stirring
overnight the solvent was removed and the salt 3was used without
further purication. A mixture of the acid 1 (984 mg, 5.16 mmol),
the potassium salt 3 (1.25 g, 5.16 mmol) and acetic anhydride (15
mL) was heated to 120 C for 5 h. The reaction was cooled to room
temperature and quenched by adding water (20 mL). The aqueous
phase was extracted with EtOAc (3  15 mL). The combined
organic phases were dried overMgSO4, ltered and the solvent was
removed under reduced pressure. The crude product was puried
by automated ash column chromatography (PE/CH2Cl2, 30–60%
CH2Cl2) to yield the maleic anhydride 4 (1.07 g, 58%) as gray solid.
Rf: 0.45 (PE/CH2Cl2: 1/1); m.p.: 205 C; IR (neat) nmax: 3108, 2922,
1843, 1766, 1629, 1539, 1460, 1252, 1047, 1177, 990, 919; 1H-NMR
(300 MHz, DMSO-d6): d ¼ 1.94 (s, 6H, thiophene-CH3), 7.03 (s, 2H,
thiophene-H); 13C-NMR (75MHz, DMSO-d6): d¼ 14.1 (+), 125.2 (q),
125.3 (q), 127.2 (+), 134.5 (q), 141.4 (q), 164.5 (q); HRMS (ESI): calcd
for C14H9Cl2O3S2 (M + H)
+ 358.9365; found 358.9362.
N2-((Benzyloxy)carbonyl)-N5-(3,4-bis(5-chloro-2-
methylthiophen-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-L-
glutamine (6)
Maleic anhydride 4 (40 mg, 0.11 mmol) was added to a solution
of acid hydrazide 5 (30 mg, 0.10 mmol) in THF (1 mL) in a crimp
top vial. Aer heating to 85 C for 16 h the reaction was18080 | RSC Adv., 2015, 5, 18075–18086quenched with 1 M aqueous HCl solution (1 mL) and water (1
mL). The aqueous phase was extracted with EtOAc (3  5 mL).
The combined organic phases were dried over MgSO4 and the
solvent was removed under reduced pressure. Purication by
automated reversed phase ash column chromatography
(MeCN/H2O with 0.05% TFA, 10–95%MeCN) yielded compound
6 (40 mg, 63%) as orange solid. Rf: 0.01 (EtOAc); m.p.: 103 C; IR
(neat) nmax: 3250, 2924, 1789, 1727, 1522, 1462, 1434, 1215, 1175,
990; 1H-NMR (300 MHz, DMSO-d6): d ¼ 1.74–1.88 (m, 1H,
CO–(CH2)2–CH), 1.94 (s, 6H, thiophene-CH3), 2.00–2.10 (m, 1H,
CO–(CH2)2–CH), 2.38–2.48 (m, 2H, CO–(CH2)2–CH), 4.03 (dt, J ¼
9.0, 4.8 Hz, 1H, CH2–CH–NH), 5.05 (s, 2H, O–CH2–Ph), 7.03 (s,
2H, thiophene-H), 7.31–7.40 (m, 5H, Ph-H), 7.68 (d, J ¼ 8.0 Hz,
1H, CH–NH–CO), 10.63 (s, 1H, N–NH–CO), 12.70 (bs, 1H,
COOH); 13C-NMR (75MHz, DMSO-d6): d¼ 14.2 (+), 26.1 (), 29.1
(), 53.1 (+), 65.4 (), 125.0 (q), 125.8 (q), 127.6 (+), 127.6 (+),
127.7 (+), 128.3 (+), 131.2 (q), 136.8 (q), 140.6 (q), 156.1 (q), 166.9
(q), 170.8 (q), 173.4 (q); HRMS (ESI): calcd for C27H24Cl2N3O7S2
(M + H)+ 636.0427; found 636.0428.
(S)-2-(((Benzyloxy)carbonyl)amino)-6-(3,4-bis(5-chloro-2-
methylthiophen-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)
hexanoic acid (7)
Triethylamine (131 mL, 0.95 mmol) was added to a suspension
of maleic anhydride 4 (97 mg, 0.27 mmol) and Cbz-Lys-OH (83
mg, 0.30 mmol) in THF (5 mL) in a crimp top vial. Aer heating
to 85 C for 16 h the reaction was quenched with 1 M aqueous
HCl solution (3 mL) and water (3 mL). The aqueous phase was
extracted with EtOAc (3  15 mL). The combined organic pha-
ses were dried over MgSO4 and the solvent was removed under
reduced pressure. Purication by automated reversed phase
ash column chromatography (MeCN/H2O with 0.05% TFA, 50–
100% MeCN) yielded compound 7 (138 mg, 82%) as orange
solid. Rf: 0.09 (PE/EtOAc: 1/1); m.p.: 88 C; IR (neat) nmax: 3351,
3095, 2932, 2870, 1698, 1526, 1438, 1404, 1211, 989; 1H-NMR
(400 MHz, DMSO-d6): d ¼ 1.29–1.43 (m, 2H, CH2–(CH2)3–CH),
1.51–1.65 (m, 3H, CH2–(CH2)3–CH), 1.67–1.79 (m, 1H,
CH2–(CH2)3–CH), 1.91 (s, 6H, thiophene-CH3), 3.49 (t, J ¼ 7.1
Hz, 2H, N–CH2–(CH2)3), 3.93 (dt, J ¼ 7.9, 4.6 Hz, 1H, NH–CH–
CH2), 5.02 (s, 2H, O–CH2–Ph), 7.00 (s, 2H, thiophene-H), 7.28–
7.37 (m, 5H, Ph-H), 7.57 (d, J ¼ 8.0 Hz, 1H, CO–NH–CH), 12.55
(s, 1H, COOH); 13C-NMR (101 MHz, DMSO-d6): d ¼ 14.1 (+), 22.8
(), 27.4 (), 30.2 (), 37.7 (), 53.5 (+), 65.3 (), 124.6 (q), 126.4
(q), 127.6 (+), 127.7 (+), 127.7 (+), 128.2 (+), 132.3 (q), 136.9 (q),
139.8 (q), 169.6 (q), 173.8 (q); HRMS (ESI): calcd for C28H27Cl2-
N2O6S2 (M + H)
+ 621.0682; found 621.0684.
N-(3,4-Bis(5-chloro-2-methylthiophen-3-yl)-2,5-dioxo-2,5-
dihydro-1H-pyrrol-1-yl)acetamide (8)
Hydrazine hydrate (39 mL, 0.81mmol) was added to a solution of
maleic anhydride 4 (97 mg, 0.27 mmol) in acetic acid (3.5 mL).
The reaction mixture was heated to 100 C for 20 h and then
water (10 mL) was added. The aqueous phase was extracted with
EtOAc (3  10 mL). The combined organic phases were dried
over MgSO4 and the solvent was evaporated in vacuo. Purica-
tion by automated ash column chromatography (PE/EtOAc,This journal is © The Royal Society of Chemistry 2015
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View Article Online15–50% EtOAc) yielded compound 8 (81 mg, 72%) as orange
solid. Rf: 0.23 (PE/EtOAc: 2/1); m.p.: 131 C; IR (neat) nmax: 3328,
3088, 2924, 2359, 1717, 1702, 1510, 1429, 1255, 1193, 988; 1H-
NMR (400 MHz, DMSO-d6): d ¼ 1.95 (s, 6H, thiophene-CH3),
2.03 (s, 3H, CO–CH3), 7.01 (s, 2H, thiophene-H), 10.58 (s, 1H,
NH); 13C-NMR (101 MHz, DMSO-d6): d ¼ 14.2 (+), 20.0 (+), 125.0
(q), 125.8 (q), 127.6 (+), 131.3 (q), 140.6 (q), 166.9 (q), 168.5 (q);
HRMS (ESI): calcd for C16H13Cl2N2O3S2 (M + H)
+ 414.9739;
found 414.9741.
3,4-Bis(5-chloro-2-methylthiophen-3-yl)-1-methyl-1H-pyrrole-
2,5-dione (9)
Maleic anhydride 4 (54 mg, 0.15 mmol) and 1,2-dimethylhy-
drazine dihydrochloride (60 mg, 0.45 mmol) were heated to 160
C for 12 h in PEG400 (2 mL) in a crimp top vial. Then water (15
mL) was added and the aqueous phase was extracted with EtOAc
(3  15 mL). The combined organic phases were washed with
brine (50 mL), dried over MgSO4 and the solvent was removed
under reduced pressure. Purication by automated ash
column chromatography (PE/EtOAc, 3–10% EtOAc) yielded
compound 9 (48 mg, 86%) as orange foam. Rf: 0.32 (PE/EtOAc:
19/1); IR (neat) nmax: 3098, 2924, 2851, 1765, 1697, 1435, 1386,
1250, 1174, 980; 1H-NMR (300 MHz, CDCl3): d ¼ 1.93 (s, 6H,
thiophene-CH3), 3.13 (s, 3H, N–CH3), 6.89 (s, 2H, thiophene-H);
13C-NMR (75 MHz, CDCl3): d ¼ 14.9 (+), 24.4 (+), 126.0 (q), 127.2
(+), 127.2 (q), 132.7 (q), 140.2 (q), 170.2 (q); HRMS (ESI): calcd
for C15H12Cl2NO2S2 (M + H)
+ 373.9649; found 373.9652.
Allyl ((4-(2-amino-2-oxoacetyl)-5-methylthiophen-2-yl)methyl)
carbamate (10)
To a solution of oxoacetate 18 (282 mg, 0.95 mmol) in THF (5
mL) was added a NH4OH solution (32% in H2O) (1.18 mL, 9.50
mmol) at 0 C. The reaction was stirred for 90 min at room
temperature and then quenched with water (5 mL). The
aqueous phase was extracted with EtOAc (3  10 mL). The
combined organic phases were dried over MgSO4 and the
solvent was removed under reduced pressure. Compound 10
(253 mg, 94%) was obtained as yellow solid and used without
further purication. Rf: 0.21 (PE/EtOAc: 1/1); m.p.: 108 C; IR
(neat) nmax: 3402, 3301, 3167, 2962, 1750, 1686, 1649, 1535, 1460,
1254, 1047, 796; 1H-NMR (400 MHz, CDCl3): d ¼ 2.70 (s, 3H,
thiophene-CH3), 4.44 (d, J ¼ 6.1 Hz, 2H, thiophene-CH2NH),
4.59 (d, J ¼ 5.1 Hz, 2H, CH2]CHCH2O), 5.21 (dd, J ¼ 10.4, 0.5
Hz, 1H, CH2]CHCH2), 5.24–5.43 (m, 2H, CH2]CHCH2 and
NH), 5.90 (ddt, J ¼ 16.2, 10.7, 5.5 Hz, 1H, CH2]CHCH2), 6.05
(bs, 1H, NH2), 7.06 (bs, 1H, NH2), 7.86 (s, 1H, thiophene-H);
13C-
NMR (101 MHz, CDCl3): d ¼ 16.7 (+), 39.8 (), 65.9 (), 117.9
(), 129.0 (+), 130.8 (q), 132.7 (+), 137.0 (q), 155.7 (q), 156.1 (q),
164.4 (q), 182.1 (q); HRMS (ESI): calcd for C12H18N3O4S (M +
NH4)
+ 300.1013; found 300.1012.
Methyl 4-(2-methoxy-2-oxoethyl)-5-methylthiophene-2-
carboxylate (11)
Thallium trinitrate (850 mg, 1.91 mmol) and 70% HClO4 (0.30
mL) were added to a suspension of 21 (316 mg, 1.59 mmol) in
MeOH (10 mL) at room temperature. Aer stirring for 24 h theThis journal is © The Royal Society of Chemistry 2015mixture was concentrated under vacuum and diluted with water
(10 mL). The aqueous phase was extracted with EtOAc (3  10
mL) and the combined organic layers were dried over MgSO4.
The solvent was evaporated and purication of the crude
product by automated ash column chromatography (PE/
EtOAc, 3–15% EtOAc) yielded compound 11 (331 mg, 91%) as
colorless oil. Rf: 0.34 (PE/EtOAc: 5/1); IR (neat) nmax: 2997, 2953,
2845, 1736, 1704, 1535, 1457, 1392, 1331, 1291, 1250, 1194,
1132, 1063, 1006, 927, 874, 785, 751; 1H-NMR (400 MHz, CDCl3):
d¼ 2.42 (s, 3H, thiophene-CH3), 3.54 (s, 2H, thiophene-CH2C(O)
OCH3), 3.69 (s, 3H, thiophene-CH2C(O)OCH3), 3.84 (s, 3H, C(O)
OCH3), 7.60 (s, 1H, thiophene-H);
13C-NMR (101 MHz, CDCl3): d
¼ 13.9 (+), 33.9 (), 52.1 (+), 52.3 (+), 129.2 (q), 130.8 (q), 135.7
(+), 144.1 (q), 162.7 (q), 171.0 (q); HRMS (APCI): calcd for
C10H12O4S (M + H)
+ 229.0529; found 229.0531.
Methyl 4-(4-(5-((((allyloxy)carbonyl)amino)methyl)-2-methyl-
thiophen-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-5-
methylthiophene-2-carboxylate (12)
KOtBu (1 M in THF, 0.88 mL, 0.88 mmol) was added to a
solution of glyoxylamide 10 (206 mg, 0.73 mmol) in anhydrous
THF (5 mL) at 0 C under nitrogen atmosphere. Aer stirring for
90 min at 0 C, diester 11 (200 mg, 0.88 mmol) in THF (2 mL)
was added at 0 C and stirred for 3 days at room temperature.
Then the reaction was quenched with 1M aqueous HCl solution
(3 mL) and diluted with EtOAc (10 mL). The organic phase was
washed with water (2  10 mL), brine (10 mL) and dried over
MgSO4. The solvent was removed under reduced pressure and
purication of the crude product by automated ash column
chromatography (PE/EtOAc, 25–50% EtOAc) yielded 12 (148 mg,
44%) as yellow foam. Rf: 0.20 (PE/EtOAc: 2/1); IR (neat) nmax:
3289, 3070, 2952, 1703, 1540, 1458, 1339, 1248, 994, 909, 727;
1H-NMR (400 MHz, CDCl3): d ¼ 1.90 (s, 3H, thiophene-CH3);
1.98 (s, 3H, thiophene-CH3), 3.87 (s, 1H, OCH3), 4.45 (d, J ¼
6.0 Hz, 2H, thiophene-CH2NH), 4.60 (d, J ¼ 4.9 Hz, 2H,
CH2]CHCH2O), 5.13–5.27 (m, 2H, CH2]CHCH2 and CH2-
NHCO), 5.31 (dd, J ¼ 17.2, 1.2 Hz, 1H, CH2]CHCH2), 5.92 (ddt,
J¼ 16.2, 10.8, 5.5 Hz, 1H, CH2]CHCH2), 6.90 (s, 1H, thiophene-
H), 7.74 (s, 1H, thiophene-H), 8.03 (bs, 1H, CONHCO); 13C-NMR
(101 MHz, CDCl3): d ¼ 15.0 (+), 15.3 (+), 39.9 (), 52.3 (+), 65.9
(), 117.9 (), 125.8 (q), 126.7 (+), 127.5 (q), 130.9 (q), 132.7 (+),
134.8 (q), 134.9 (+), 139.4 (q), 142.1 (q), 148.6 (q), 156.0 (q), 162.1
(q), 170.0 (q), 170.2 (q); HRMS (ESI): calcd for C21H21N2O6S2 (M
+ H)+ 461.0838; found 461.0836.
4-(4-(5-(Aminomethyl)-2-methylthiophen-3-yl)-2,5-dioxo-2,5-
dihydro-1H-pyrrol-3-yl)-5-methylthiophene-2-carboxylic acid
(13a) and 4-(4-(5-((((allyloxy)carbonyl)amino)methyl)-2-
methylthiophen-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-5-
methylthiophene-2-carboxylic acid (13b)
A solution of BBr3 (1 M in CH2Cl2, 2.0 mL, 2.00 mmol) was
added to a solution of compound 12 (92 mg, 0.20 mmol) in
anhydrous CH2Cl2 (6 mL) in a crimp top vial. The mixture was
heated to 40 C for 5 h. Then water (4 mL) was added via syringe
and the suspension was stirred at 40 C for additional 30 min.
Aer cooling to room temperature the solvent was removed atRSC Adv., 2015, 5, 18075–18086 | 18081
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View Article Onlinethe rotary evaporator. Purication by automated reversed phase
ash column chromatography (MeCN/H2O with 0.05% TFA, 3–
100% MeCN) yielded compound 13a (34 mg, 47%) as yellow
solid and compound 13b (18 mg, 20%) as yellow solid.
Analytical data of 13a
Rf: 0.02 (PE/EtOAc: 1/1); m.p.: 173 C; IR (neat) nmax: 3008, 2924,
1766, 1712, 1681, 1545, 1463, 1344, 1188, 1137, 1001, 839, 799,
756, 723; 1H-NMR (600MHz, MeOD): d¼ 2.00 (s, 3H, thiophene-
CH3), 2.08 (s, 3H, thiophene-CH3), 4.27 (s, 2H, thiophene-
CH2NH), 7.18 (s, 1H, thiophene-H), 7.64 (s, 1H, thiophene-H);
13C-NMR (151 MHz, MeOD): d¼ 14.7 (+), 15.3 (+), 38.5 (), 128.5
(q), 129.3 (q), 132.2 (+), 132.8 (q), 133.1 (q), 135.0 (q), 135.7 (q),
136.3 (+), 144.6 (q), 149.7 (q), 164.6 (q), 172.4 (q), 172.6 (q);
HRMS (ESI): calcd for C16H15N2O4S2 (M + H)
+ 363.0469; found
363.0468.
Analytical data of 13b
Rf: 0.04 (PE/EtOAc: 1/1); m.p.: 94 C; IR (neat) nmax: 2926, 1981,
1769, 1709, 1544, 1459, 1344, 1246, 1185, 1150, 1049, 991, 849,
762; 1H-NMR (300 MHz, CD3CN): d ¼ 1.93 (s, 3H, thiophene-
CH3), 1.97 (s, 3H, thiophene-CH3), 4.33 (d, J ¼ 6.3 Hz, 2H,
thiophene-CH2NH), 4.52 (d, J ¼ 5.3 Hz, 2H, CH2]CHCH2O),
5.18 (dd, J ¼ 10.5, 1.4 Hz, 1H, CH2]CHCH2), 5.27 (dd, J ¼ 17.3,
1.6 Hz, 1H, CH2]CHCH2), 5.74–6.05 (m, 1H, CH2]CHCH2),
6.14 (bs, 1H, CH2NHCO), 6.79 (s, 1H, thiophene-H), 7.60 (s, 1H,
thiophene-H), 8.80 (bs, 1H, COOH); 13C-NMR (75 MHz, CD3CN):
d¼ 14.8 (+), 15.2 (+), 40.1 (), 66.0 (), 117.5 (), 127.2 (q), 127.4
(+), 129.1 (q), 131.4 (q), 134.1 (q), 134.4 (+), 136.2 (+), 136.2 (q),
141.2 (q), 141.8 (q), 149.6 (q), 157.1 (q), 162.9 (q), 171.6 (q), 171.7
(q); HRMS (ESI): calcd for C20H18N2O6S2 (M + H)
+ 447.0679;
found 447.0676.
Alternative procedure to obtain 13b
Compound 12 (40 mg, 0.09 mmol) was dissolved in acetone (10
mL) and LiI (350 mg, 2.60 mmol) was added. The mixture was
heated to 100 C overnight. Aer cooling to room temperature it
was quenched with 1 M aqueous HCl solution (5 mL) and
diluted with CH2Cl2 (5 mL). The phases were separated and the
aqueous phase was extracted with CH2Cl2 (3  5 mL). The
combined organic phases were dried over Na2SO4 and the
solvent was removed at the rotary evaporator. Automated
reversed phase ash column chromatography (MeCN/H2O with
0.05% TFA, 3–100% MeCN) yielded compound 13b (14 mg,
35%) as yellow solid.
Allyl ((5-methylthiophen-2-yl)methyl)carbamate (17)
LAH (2.78 g, 73.2 mmol) was added in portions to a solution of
nitrile 16 (3.01 g, 24.4 mmol) in anhydrous Et2O (250mL) at 0 C
under nitrogen atmosphere. Aer stirring for 4 h at room
temperature the reaction was quenched with water (80 mL) and
saturated aqueous NaHCO3 solution (50 mL) at 0 C. The
suspension was ltered and the aqueous phase was extracted
with Et2O (3 80mL). The combined organic phases were dried
over MgSO4 and concentrated in vacuo. Then the residue was18082 | RSC Adv., 2015, 5, 18075–18086dissolved in anhydrous THF (100 mL) and pyridine (2.47 mL,
30.50 mmol) was added at 0 C. Within 1 h allyl chloroformate
(4.02 mL, 37.82 mmol) in anhydrous THF (5 mL) was dropped to
the solution via a syringe pump at 0 C. Aer stirring for 14 h at
room temperature the reaction was quenched cautiously with
water (50 mL) and extracted with EtOAc (3  30 mL). The
combined organic phases were dried over MgSO4 and the
solvent was removed under reduced pressure. Purication of
the crude product by automated ash column chromatography
(PE/EtOAc, 8–15% EtOAc) yielded 17 (3.40 g, 66%) as yellow oil.
Rf: 0.20 (PE/EtOAc: 9/1); IR (neat) nmax: 3335, 3073, 2922, 1695,
1514, 1426, 1236, 982, 799; 1H-NMR (400 MHz, CDCl3): d ¼ 2.44
(s, 3H, thiophene-CH3), 4.44 (d, J ¼ 5.7 Hz, 2H, thiophene-
CH2NH), 4.61 (d, J ¼ 5.3 Hz, 2H, CH2]CHCH2O), 5.05 (bs, 1H,
NH), 5.25 (dd, J ¼ 10.4, 0.3 Hz, 1H, CH2]CHCH2), 5.30 (dd, J ¼
17.1, 1.2 Hz, 1H, CH2]CHCH2), 5.92 (ddt, J¼ 16.4, 10.8, 5.7 Hz,
1H, CH2]CHCH2), 6.57 (dd, J¼ 3.1, 1.0 Hz, 1H, 4-thiophene-H),
6.74 (d, J ¼ 3.1 Hz, 1H, 3-thiophene-H); 13C-NMR (101 MHz,
CDCl3): d¼ 15.4 (+), 40.1 (), 65.7 (), 117.8 (), 124.8 (+), 125.7
(+), 132.8 (+), 138.8 (q), 139.9 (q), 155.9 (q); HRMS (ESI): calcd for
C10H14NO2S (M + H)
+ 212.0740; found 212.0740.
Methyl 2-(5-((((allyloxy)carbonyl)amino)methyl)-2-
methylthiophen-3-yl)-2-oxoacetate (18)
Carbamate 17 (169 mg, 0.80 mmol) and methyl chloroox-
oacetate (81 mL, 0.88 mmol) were dissolved in anhydrous
CH2Cl2 (6 mL) under nitrogen atmosphere. Then aluminum
chloride (427 mg, 3.20 mmol) was added in portions at 0 C and
the suspension was stirred for 20 h at room temperature. The
reaction was quenched with saturated aqueous NaHCO3 solu-
tion (1 mL) at 0 C and diluted with water (5 mL). The aqueous
phase was extracted with CH2Cl2 (3  5 mL), the combined
organic layers were washed with brine (10 mL) and dried over
MgSO4. Aer evaporation of the solvent the crude product was
puried by automated ash column chromatography (PE/
EtOAc, 15–40% EtOAc) to obtain 18 (117 mg, 49%) as brown
oil. Rf: 0.22 (PE/EtOAc: 3/1); IR (neat) nmax: 3395, 2954, 1726,
1670, 1517, 1434, 1242, 1200, 1112, 984, 757; 1H-NMR (400MHz,
CDCl3): d¼ 2.70 (s, 3H, thiophene-CH3), 3.91 (s, 3H, OCH3), 4.42
(d, J ¼ 6.1 Hz, 2H, thiophene-CH2NH), 4.58 (d, J ¼ 5.3 Hz, 2H,
CH2]CHCH2O), 5.16–5.34 (m, 3H, CH2]CHCH2 and NH), 5.90
(ddt, J ¼ 16.3, 10.8, 5.6 Hz, 1H, CH2]CHCH2), 7.32 (s, 1H,
thiophene-H); 13C-NMR (101 MHz, CDCl3): d¼ 16.3 (+), 39.7 (),
52.8 (+), 65.9 (), 118.0 (), 127.5 (+), 131.0 (q), 132.6 (+), 138.0
(q), 154.8 (q), 156.1 (q), 164.0 (q), 180.0 (q); HRMS (ESI): calcd
for C13H16NO5S (M + H)
+ 298.0744; found 298.0744.
Methyl 4-acetyl-5-methylthiophene-2-carboxylate (21)
Thiophene 20 (800 mg, 5.12 mmol) and acetyl chloride (550 mL,
7.68 mmol) were dissolved in puried anhydrous CHCl3 (10 mL)
under nitrogen atmosphere. Aer cooling to 0 C aluminum
chloride (2.05 g, 15.4 mmol) was added in small portions. The
yellow suspension was heated to 45 C overnight upon turning
bright red, then the reaction was quenched with ice/water and
the aqueous phase was extracted with EtOAc (3  10 mL). The
combined organic phases were washed with a saturatedThis journal is © The Royal Society of Chemistry 2015
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View Article Onlineaqueous solution of NaHCO3 (10 mL) and brine (10 mL). The
organic phase was dried over MgSO4 and the solvent was
evaporated. The crude product was puried by automated ash
column chromatography (PE/EtOAc, 5–25% EtOAc) and
compound 21 (781 mg, 77%) was obtained as colorless solid. Rf:
0.41 (PE/EtOAc: 3/1); m.p.: 84 C; IR (neat) nmax: 3007, 2957,
1717, 1678, 1539, 1457, 1439, 1254, 1233, 1074, 1021, 745; 1H-
NMR (300 MHz, CDCl3): d ¼ 2.52 (s, 3H, thiophene-CH3), 2.76
(s, 3H, acetyl-CH3), 3.88 (s, 3H, OCH3), 8.03 (s, 1H, thiophene-H);
13C-NMR (75 MHz, CDCl3): d ¼ 16.8 (+), 29.6 (+), 52.3 (+), 128.5
(q), 135.0 (+), 136.3 (q), 155.8 (q), 162.0 (q), 193.7 (q); HRMS
(APCI): calcd for C9H10O3S (M + H)
+ 199.0423; found 199.0424.General procedure A: Suzuki coupling
To a suspension of Pd2(dba)3 (5 mol%), XPhos (10 mol%), the
appropriate boronic acid (1.5 eq.) and K3PO4 (1.5 eq.) in 1,4-
dioxane (0.5 M) the appropriate ester (1.0 eq.) was added. The
resulting mixture was heated to 100 C and stirred
overnight. Aer cooling to room temperature the reaction
mixture was diluted with EtOAc and the organic phase was
washed two times with water. The organic phase was dried over
MgSO4, ltered and the solvent was removed under reduced
pressure.General procedure B: aminolysis
An NH4OH solution (25% in H2O) (10.0 eq.) was added to a
solution of the appropriate oxoacetate (1.0 eq.) in THF (0.3 M) at
0 C. The reaction was stirred for 1 h at room temperature and
then quenched with water. The aqueous phase was extracted
with EtOAc. The combined organic phases were dried over
MgSO4, ltered and the solvent was removed under reduced
pressure.General procedure C: Perkin condensation
KOtBu (1 M in THF) (1.2 eq.) was added to a solution of the
appropriate amide (1.0 eq.) in THF (0.2 M) at 0 C. Aer 90 min
stirring at 0 C the appropriate ester (1.0 eq.) was added at 0 C
and stirred overnight at room temperature. The reaction was
quenched with 1 M HCl and diluted with EtOAc. The organic
phase was washed three times with water and one time with
brine. The organic phase was dried over MgSO4, ltered and the
solvent was removed under reduced pressure.2-(5-Chloro-2-methylthiophen-3-yl)-2-oxoacetamide (23)
Compound 23 was prepared from 28 (800 mg, 3.66 mmol)
according to general procedure B. The amide 23 (640 mg, 85%)
was obtained as light yellow solid and used without further
purication. m.p.: 183 C; IR (neat) nmax: 3446, 3252, 1996, 1670,
1618, 1296, 1221, 1153; 1H-NMR (300 MHz, DMSO-d6): d ¼ 2.64
(s, 3H, thiophene-CH3), 7.49 (s, 1H, thiophene-H), 7.94 (bs, 1H,
NH), 8.25 (bs, 1H, NH); 13C-NMR (75 MHz, DMSO-d6): d ¼ 15.2
(+), 123.9 (q), 128.4 (+), 131.4 (q), 150.9 (q), 166.1 (q), 184.2 (q);
HRMS (ESI): calcd for C7H10ClN2O2S (M + NH4)
+ 221.0146;
found 221.0144.This journal is © The Royal Society of Chemistry 20153,4-Bis(5-chloro-2-methylthiophen-3-yl)-1H-pyrrole-2,5-dione
(24)
Compound 24 was prepared from amide 23 (600 mg, 2.95
mmol) and ester 22 (720 mg, 3.54 mmol) according to general
procedure C. Purication by automated ash column chroma-
tography (heptane/EtOAc: 5/1) yielded 24 (660 mg, 63%) as
orange solid. Rf: 0.18 (heptane/EtOAc: 5/1); m.p.: 237 C; IR
(neat) nmax: 3381, 2939, 2818, 1653, 1437, 1002;
1H-NMR (400
MHz, DMSO-d6): d ¼ 1.87 (s, 6H, thiophene-CH3), 6.97 (s, 2H,
thiophene-H), 11.25 (bs, 1H, NH); 13C-NMR (101 MHz, DMSO-
d6): d ¼ 14.6 (+), 125.0 (q), 127.0 (q), 128.4 (+), 133.6 (q), 140.0
(q), 171.4 (q); HRMS (ESI): calcd for C14H10Cl2NO2S2 (M + H)
+
357.9525; found 357.9523.Methyl 2-(5-(4-(tert-butyl)phenyl)-2-methylthiophen-3-yl)
acetate (26)
Compound 26 was prepared from 22 (200 mg, 0.98 mmol)
according to general procedure A. Purication by automated
ash column chromatography (PE/EtOAc, 0–25% EtOAc) yiel-
ded 26 (163 mg, 55%) as yellow liquid. Rf: 0.63 (PE/EtOAc: 5/1);
IR (neat) nmax: 2961, 1736, 1609, 1520, 1435, 1364, 1239, 1018,
825; 1H-NMR (300 MHz, CDCl3): d ¼ 1.33 (s, 9H, tBu), 2.41 (s,
3H, thiophene-CH3), 3.55 (s, 2H, thiophene-CH2C(O)OCH3),
3.71 (s, 3H, thiophene-CH2C(O)OCH3), 7.08 (s, 1H, thiophene-
H), 7.32–7.40 (m, 2H, Ph), 7.43–7.52 (m, 2H, Ph); 13C-NMR (75
MHz, CDCl3): d ¼ 13.3 (+), 31.3 (+), 34.1 (), 34.6 (q), 52.1 (+),
124.7 (+), 125.2 (+), 125.7 (+), 130.1 (q), 131.6 (q), 134.8 (q), 140.1
(q), 150.2 (q), 171.6 (q); HRMS (ESI): calcd for C18H23O2S (M +
H)+ 303.1413; found 303.1418.Methyl 2-(5-([1,10-biphenyl]-3-yl)-2-methylthiophen-3-yl)
acetate (27)
Compound 27 was prepared from 22 (500 mg, 2.44 mmol)
according to general procedure A. Purication by automated
ash column chromatography (PE/EtOAc, 0–15% EtOAc) yiel-
ded 27 (569 mg, 72%) as yellow liquid. Rf: 0.50 (PE/EtOAc: 5/1);
IR (neat) nmax: 1707, 1597, 1449, 1262, 1174, 755, 696;
1H-NMR
(300 MHz, CDCl3): d ¼ 2.44 (s, 3H, thiophene-CH3), 3.58 (s,
2H, thiophene-CH2C(O)OCH3), 3.72 (s, 3H, thiophene-CH2C(O)
OCH3), 7.19 (s, 1H, thiophene-H), 7.37–7.45 (m, 3H, Ph), 7.46–
7.54 (m, 3H, Ph), 7.59–7.66 (m, 2H, Ph), 7.74–7.76 (m, 1H, Ph);
13C-NMR (75 MHz, CDCl3): d¼ 2.44 (s, 3H, thiophene-CH3), 3.58
(s, 2H, thiophene-CH2C(O)OCH3), 3.72 (s, 3H, thiophene-
CH2C(O)OCH3), 7.19 (s, 1H, thiophene-H), 7.37–7.42 (m, 1H,
Ph), 7.43–7.47 (m, 3H, Ph), 7.48–7.54 (m, 2H, Ph), 7.60–7.65 (m,
2H, Ph), 7.74–7.76 (m, 1H, Ph); 13C-NMR (75 MHz, CDCl3): d ¼
13.3 (+), 34.1 (), 52.1 (+), 124.3 (+), 124.4 (+), 125.3 (+), 126.0 (+),
127.2 (+), 127.5 (+), 128.8 (+), 129.2 (+), 130.3 (q), 134.8 (q), 135.5
(q), 139.9 (q), 140.9 (q), 141.9 (q), 171.5 (q); HRMS (EI): calcd for
C20H18O2S (M
+c) 322.1028; found 322.1032.Methyl 2-(5-(4-(tert-butyl)phenyl)-2-methylthiophen-3-yl)-2-
oxoacetate (30)
Compound 30 was prepared from 28 (500 mg, 2.29 mmol)
according to general procedure A. Purication by automatedRSC Adv., 2015, 5, 18075–18086 | 18083
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View Article Onlineash column chromatography (PE/EtOAc, 0–15% EtOAc) yiel-
ded 30 (350 mg, 48%) as dark yellow liquid. Rf: 0.67 (PE/EtOAc:
5/1); IR (neat) nmax: 2961, 2866, 1732, 1676, 1456, 1191, 1127,
993, 753; 1H-NMR (300 MHz, CDCl3): d ¼ 1.34 (s, 9H, tBu), 2.78
(s, 3H, thiophene-CH3), 3.96 (s, 3H, thiophene-CH2C(O)OCH3),
7.39–7.44 (m, 2H, Ph), 7.46–7.51 (m, 2H, Ph), 7.63 (s, 1H, thio-
phene-H); 13C-NMR (75 MHz, CDCl3): d ¼ 16.3 (+), 31.3 (+), 34.7
(q), 52.8 (+), 124.2 (+), 125.6 (+), 126.0 (+), 130.3 (q), 132.2 (q),
140.5 (q), 151.3 (q), 153.5 (q), 164.1 (q), 180.2 (q); HRMS (EI):
calcd for C18H20O3S (M
+c) 316.1133; found 316.1139.Methyl 2-(5-([1,10-biphenyl]-3-yl)-2-methylthiophen-3-yl)-2-
oxoacetate (31)
Compound 31 was prepared from 28 (500 mg, 2.29 mmol)
according to general procedure A. Purication by automated
ash column chromatography (PE/EtOAc, 0–15% EtOAc) yiel-
ded 31 (537 mg, 70%) as yellow oil. Rf: 0.40 (PE/EtOAc: 5/1); IR
(neat) nmax: 3028, 1724, 1668, 1598, 1464, 1197, 1132, 1000, 748,
695; 1H-NMR (300 MHz, CDCl3): d ¼ 2.81 (s, 3H, thiophene-
CH3), 3.98 (s, 3H, thiophene-CH2C(O)OCH3), 7.36–7.43 (m, 1H,
Ph), 7.45–7.49 (m, 2H, Ph), 7.50–7.57 (m, 3H, Ph), 7.60–7.65 (m,
2H, 4-H, Ph), 7.73–7.76 (m, 2H, Ph, thiophene-H); 13C-NMR (75
MHz, CDCl3): d ¼ 16.4 (+), 52.9 (+), 124.6 (+), 124.7 (+), 124.8 (+),
126.9 (+), 127.2 (+), 127.7 (+), 128.9 (+), 129.5 (+), 132.3 (q), 133.5
(q), 140.2 (q), 140.6 (q), 142.2 (q), 154.0 (q), 164.0 (q), 180.1 (q);
HRMS (ESI): calcd for C20H15O2S (M + H
+)  (H2O) 319.0787;
found 319.0787.2-(5-(4-(tert-Butyl)phenyl)-2-methylthiophen-3-yl)-2-
oxoacetamide (33)
Compound 33 was prepared from 30 (312 mg, 0.99 mmol)
according to general procedure B. The amide 33 (250 mg, 84%)
was obtained as light yellow solid and used without further
purication. m.p.: 202 C; IR (neat) nmax: 3395, 2955, 1712, 1651,
1454, 1191, 575; 1H-NMR (300 MHz, DMSO-d6): d ¼ 1.29 (s, 9H,
tBu), 2.71 (s, 3H, thiophene-CH3), 7.36–7.48 (m, 2H, Ph), 7.51–
7.59 (m, 2H, Ph), 7.74 (s, 1H, thiophene-H), 7.91 (s, 1H, NH),
8.26 (s, 1H, NH); 13C-NMR (75 MHz, DMSO-d6): d¼ 15.4 (+), 30.9
(+), 34.3 (q), 124.4 (+), 125.0 (+), 126.0 (+), 129.7 (q), 133.0 (q),
138.9 (q), 150.5 (q), 150.6 (q), 167.0 (q), 185.5 (q); HRMS (ESI):
calcd for C17H20NO2S (M + H
+) 303.1240; found 303.1240.2-(5-([1,10-Biphenyl]-3-yl)-2-methylthiophen-3-yl)-2-
oxoacetamide (34)
Compound 34 was prepared from 31 (250 mg, 0.74 mmol)
according to general procedure B. The amide 34 (224 mg, 94%)
was obtained as light yellow solid and used without further
purication. m.p.: 151 C; IR (neat) nmax: 3393, 3302, 3184, 1721,
1652, 1597, 1456, 1352, 1196, 747, 689, 608; 1H-NMR (300 MHz,
DMSO-d6): d ¼ 2.73 (s, 3H, thiophene-CH3), 7.39–7.44 (m, 1H,
Ph), 7.47–7.56 (m, 3H, Ph), 7.58–7.66 (m, 2H, Ph), 7.71–7.75 (m,
2H, Ph), 7.83–7.85 (m, 1H, NH), 7.93 (bs, 2H, Ph, thiophene-H),
8.28 (bs, 1H, NH); 13C-NMR (75 MHz, DMSO-d6): d ¼ 15.4 (+),
123.4 (+), 124.4 (+), 125.5 (+), 126.4 (+), 126.8 (+), 127.7 (+), 128.9
(+), 129.9 (+), 133.1 (q), 133.2 (q), 138.7 (q), 139.5 (q), 141.1 (q),18084 | RSC Adv., 2015, 5, 18075–18086151.1 (q), 166.9 (q), 185.6 (q); HRMS (ESI): calcd for C19H16NO2S
(M + H+) 322.0896; found 322.0893.
3-(5-(4-(tert-Butyl)phenyl)-2-methylthiophen-3-yl)-4-(5-chloro-
2-methylthiophen-3-yl)-1H-pyrrole-2,5-dione (35)
Compound 35 was prepared from amide 23 (100 mg, 0.49
mmol) and ester 26 (178 mg, 0.59 mmol) according to general
procedure C. Purication by automated ash column chroma-
tography (PE/EtOAc, 0–25% EtOAc) yielded 35 (62 mg, 28%) as
dark green solid. Rf: 0.47 (PE/EtOAc: 5/1); m.p.: 145 C; IR (neat)
nmax: 3055, 2961, 1707, 1459, 1338, 1181, 1018, 987, 825;
1H-
NMR (300 MHz, DMSO-d6): d ¼ 1.28 (s, 9H, tBu), 1.88 (s, 3H,
thiophene-CH3), 1.99 (s, 3H, thiophene-CH3), 7.02 (s, 1H, thio-
phene-H), 7.28 (s, 1H, thiophene-H), 7.40–7.49 (m, 4H, Ph),
11.27 (s, 1H, NH); 13C-NMR (75 MHz, DMSO-d6): d ¼ 14.0 (+),
14.2 (+), 30.9 (+), 34.2 (q), 124.0 (+), 124.3 (q), 124.7 (+), 125.9 (+),
126.7 (q), 127.8 (q), 127.9 (+), 130.2 (q), 132.7 (q), 134.1 (q), 139.3
(q), 139.5 (q), 139.8 (q), 150.3 (q), 171.0 (q), 171.1 (q); HRMS
(ESI): calcd for C24H26ClN2O2S2 (M + NH4)
+ 473.1119; found
473.1116.
3-(5-([1,10-Biphenyl]-3-yl)-2-methylthiophen-3-yl)-4-(5-chloro-
2-methylthiophen-3-yl)-1H-pyrrole-2,5-dione (36)
Compound 36 was prepared from amide 23 (100 mg, 0.49
mmol) and ester 27 (160 mg, 0.49 mmol) according to general
procedure C. Purication by automated ash column chroma-
tography (PE/EtOAc, 0–25% EtOAc) yielded 36 (63 mg, 27%) as
dark red solid. Rf: 0.16 (PE/EtOAc: 5/1); m.p.: 137 C; IR (neat)
nmax: 2736, 1705, 1338, 1022, 1006, 756, 700;
1H-NMR (300 MHz,
DMSO-d6): d ¼ 1.91 (s, 3H, thiophene-CH3), 2.01 (s, 3H, thio-
phene-CH3), 7.03 (s, 1H, thiophene-H), 7.37–7.44 (m, 1H, Ph),
7.46–7.56 (m, 5H, thiophene-H, Ph), 7.58–7.63 (m, 1H, Ph),
7.69–7.75 (m, 2H, Ph), 7.77–7.79 (m, 1H, Ph), 11.30 (s, 1H, NH);
13C-NMR (75 MHz, DMSO-d6): d ¼ 14.1 (+), 14.2 (+), 123.2 (+),
124.1 (+), 124.3 (q), 125.1 (+), 126.1 (+), 126.6 (q), 126.7 (+), 127.7
(+), 127.9 (+), 128.0 (q), 128.9 (+), 129.8 (+), 132.8 (q), 133.6 (q),
134.0 (q), 139.4 (q), 139.5 (q), 139.6 (q), 140.2 (q), 141.1 (q), 171.0
(q), 171.1 (q); HRMS (ESI): calcd for C26H22ClN2O2S2 (M + NH4)
+
493.0806; found 493.0804.
3-(5-([1,10-Biphenyl]-3-yl)-2-methylthiophen-3-yl)-4-(5-(4-(tert-
butyl)phenyl)-2-methylthiophen-3-yl)-1H-pyrrole-2,5-dione
(37)
Compound 37 was prepared from amide 33 (260 mg, 0.86
mmol) and ester 27 (277 mg, 0.86 mmol) according to general
procedure C. Purication by automated ash column chro-
matography (PE/EtOAc, 0–15% EtOAc) yielded 37 (155 mg,
33%) as purple solid. Rf: 0.13 (PE/EtOAc: 5/1); m.p.: 145 C; IR
(neat) nmax: 2921, 2851, 1707, 1334, 831, 756;
1H-NMR (300
MHz, DMSO-d6): d ¼ 1.27 (s, 9H, tBu), 2.02 (s, 6H, thiophene-
CH3, thiophene-CH3), 7.31 (s, 1H, thiophene-H), 7.38–7.43 (m,
3H, Ph), 7.44–7.50 (m, 5H, thiophene-H, Ph), 7.50–7.52 (m, 1H,
Ph), 7.54–7.56 (m, 1H, Ph), 7.58–7.61 (m, 1H, Ph), 7.68–7.71 (m,
2H, Ph), 7.76–7.78 (m, 1H, Ph), 11.27 (s, 1H, NH); 13C-NMR (75
MHz, DMSO-d6): d ¼ 14.3 (+), 31.0 (+), 34.3 (q), 123.2 (+), 124.1
(+), 124.2 (+), 124.8 (+), 125.4 (+), 126.0 (+), 126.1 (+), 126.8 (+),This journal is © The Royal Society of Chemistry 2015
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View Article Online127.7 (+), 128.2 (q), 128.3 (q), 128.9 (+), 129.9 (+), 130.3 (q),
133.7 (q), 133.9 (q), 134.0 (q), 139.4 (q), 139.5 (q), 139.6 (q),
139.8 (q), 140.1 (q), 141.1 (q), 150.3 (q), 171.6 (q), 171.7 (q); HR-
MS (ESI): calcd for C36H32NO2S2 (M + H)
+ 576.1879; found
576.1875.Acknowledgements
CF thanks the graduate research training group GRK 1910 for
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